NCT01501565

Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery

Ultrasound-guided Analgesic Transverse Abdominal Plain Blockade in the Multimodal Pain Management for Laparoscopic Urological Surgery. Analgesic Efficacy Assessment.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 141 (actual)
• Sponsor: Fundacio Puigvert · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare pain level (according to numerical score)at 4, 8, 12 and 24 postoperative hours between patients under transverse abdominal plain blockade (TAP) and patients under conventional analgesia. Also the opioid consumption is assessed.

Conditions

• Postoperative Pain

Interventions

Type	Name	Description
PROCEDURE	Postoperative transverse abdominal plain (TAP) blockade	Bupivacaine 0.25%. Maximum 150 mg. A maximum of 75 mg bupivacaine is administered in each side (posterior and subcostal TAP) in a single puncture.

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-11-01
• Completion: 2012-11-01
• First posted: 2011-12-29
• Last updated: 2012-11-16

Locations

1 site across 1 country: Spain